Avedro Inc (NASDAQ:AVDR) Sees Large Decrease in Short Interest
Avedro Inc (NASDAQ:AVDR) saw a large drop in short interest in June. As of June 30th, there was short interest totalling 215,800 shares, a drop of 15.6% from the May 30th total of 255,800 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average daily volume of 112,600 shares, the short-interest ratio is currently 1.9 days.
AVDR stock traded down $0.29 during trading on Friday, reaching $19.69. The company had a trading volume of 56,410 shares, compared to its average volume of 134,925. The business has a 50-day simple moving average of $19.40. The company has a quick ratio of 9.09, a current ratio of 9.60 and a debt-to-equity ratio of 0.36. Avedro has a twelve month low of $10.75 and a twelve month high of $22.52.
Avedro (NASDAQ:AVDR) last released its earnings results on Thursday, May 9th. The company reported ($1.00) EPS for the quarter, topping analysts’ consensus estimates of ($1.01) by $0.01. The company had revenue of $8.77 million during the quarter, compared to analyst estimates of $7.93 million. On average, equities research analysts expect that Avedro will post -2.25 earnings per share for the current year.
Avedro Company Profile
Avedro, Inc, an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations.
Read More: Liquidity
Receive News & Ratings for Avedro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avedro and related companies with MarketBeat.com's FREE daily email newsletter.